The market has remained seamless over the past seven days, but has increased by 9.9% over the past year, and the income is expected to increase by 15% per year. In such a landscape, shares with strong finances become very important for investors looking for value and growth opportunities. Despite their outdated name, Penny’s shares continue to be relevant because they often represent smaller or newer companies that can provide great potential when they are supported by solid foundations.
|
Name |
Stock price |
The top limit of the market |
Financial health rating |
|
Empire Oil (IMP) |
$ 3.57 |
$ 122.52 million USD |
★★★★★ |
|
New Horizon Aircraft (Hovr) |
$ 2.27 |
$ 71.56 million USD |
★★★★★ |
|
Waterdrop (WDH) |
$ 1.34 |
473.78 million USD |
★★★★★ |
|
Greenland Technology Stay (GTEC) |
$ 2.11 |
37.22 million USD |
★★★★★ |
|
WM technology (maps) |
$ 1.07 |
$ 174.9 million USD |
★★★★★ |
|
Perfect (perf) |
$ 2.02 |
206.75 million USD |
★★★★★ |
|
Flexible Solutions International (FSI) |
$ 4.42 |
55.14 million USD |
★★★★★ |
|
Beans (BABB) |
$ 0.84176 |
$ 6.05 million USD |
★★★★★ |
|
LIFETIME brands (LCUT) |
$ 3.78 |
86.74 million USD |
★★★★ h☆ |
|
Tetra Technologies (tti) |
$ 3.74 |
512.33 million USD |
★★★★ ☆☆ |
Click here to see the full 716 shares from our US Penny stock display list.
Here’s a look at a few choices from the screen.
Just Wall Stri financial health rating: ★★★★ ☆☆
Overview: RF Industries, Ltd. Design, produce and connect products and systems worldwide with a market limit of $ 47.69 million. USD.
Operations: The company’s income segments are not reported.
Market Limit: 47.69 million USD
RF Industries with a market limit of $ 47.69 million. USD, showed some financial resistance despite being unprofitable. The company reported that in the second 2025 In the quarter, sales increased to $ 18.91 million. USD compared to $ 16.11 million. Its management and the Board are under the age of 4.9 and 6, respectively, and current assets conveniently include both short-term and long-term obligations, which indicate the management of reliable liquidity, taking into account the constant challenges in achieving profitability.
Just Wall Stri financial health rating: ★★★★★
Overview: Caribou Biosciences, Inc. There is a clinical stage biopharmaceutical company focused on alogenic cell therapy edited by genome for hematological tumors and autoimmune diseases with a top limit of approximately $ 107.89 million. USD.
Operations: Companies’ income first stems from the effort to create a pipeline of the CAR-T and CAR-NK cell treatment, which plays 9.92 million. USD.
